Theriva Biologics, Inc.
TOVX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11,609 | $23,177 | $41,786 | $67,325 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3,323 | $1,940 | $231 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,349 | $2,286 | $3,503 | $1,533 |
| Total Curr. Assets | $16,281 | $27,403 | $45,520 | $68,858 |
| Property Plant & Equip (Net) | $1,542 | $2,181 | $1,544 | $1,484 |
| Goodwill | $0 | $5,700 | $5,525 | $0 |
| Intangibles | $17,358 | $19,755 | $19,150 | $0 |
| Long-Term Investments | $0 | $102 | $99 | $0 |
| Tax Assets | $0 | $0 | $3,169 | $0 |
| Other NC Assets | $171 | $78 | -$3,146 | $23 |
| Total NC Assets | $19,071 | $27,816 | $26,341 | $1,507 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $35,352 | $55,219 | $71,861 | $70,365 |
| Liabilities | – | – | – | – |
| Payables | $859 | $770 | $915 | $524 |
| Short-Term Debt | $600 | $550 | $273 | $124 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6,126 | $5,418 | $5,872 | $2,906 |
| Total Curr. Liab. | $7,585 | $6,738 | $7,060 | $3,554 |
| LT Debt | $965 | $1,604 | $1,408 | $1,403 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $762 | $0 | $1,618 | $0 |
| Other NC Liab. | $6,973 | $7,180 | $7,211 | $0 |
| Total NC Liab. | $8,700 | $8,784 | $10,237 | $1,403 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,412 | $1,929 | $1,403 | $1,527 |
| Total Liabilities | $16,285 | $15,522 | $17,297 | $4,957 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $2,734 | $2,734 | $0 |
| Common Stock | $3 | $18 | $16 | $13 |
| Retained Earnings | -$334,971 | -$309,318 | -$290,969 | -$271,284 |
| AOCI | -$1,178 | $32 | -$679 | $0 |
| Other Equity | $355,213 | $346,231 | $343,462 | $336,679 |
| Total Equity | $19,067 | $39,697 | $54,564 | $65,408 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $35,352 | $55,219 | $71,861 | $70,365 |
| Net Debt | -$10,044 | -$21,023 | -$40,105 | -$65,798 |